Provided by Tiger Trade Technology Pte. Ltd.

LIFETECH SCI

1.720
+0.0402.38%
Volume:13.81M
Turnover:23.53M
Market Cap:7.97B
PE:33.87
High:1.720
Open:1.680
Low:1.660
Close:1.680
52wk High:2.440
52wk Low:1.260
Shares:4.63B
HK Float Shares:4.63B
Volume Ratio:1.36
T/O Rate:0.30%
Dividend:- -
Dividend Rate:- -
EPS(LYR):0.051
ROE:0.69%
ROA:0.85%
PB:1.87
PE(LYR):33.87
PS:5.31

Loading ...

Assessing LifeTech Scientific (SEHK:1302) Valuation Following Latest Board and Leadership Appointments

Simply Wall St.
·
Nov 30, 2025

BRIEF-LifeTech Scientific Says Ruan Xingmei Resigns As Executive Director

Reuters
·
Nov 21, 2025

LIFETECH SCI (01302): Chen Dongxia Appointed as Independent Non-Executive Director

Stock News
·
Nov 21, 2025

LifeTech Scientific Corporation Files Director List with HKEX

Reuters
·
Nov 21, 2025

LifeTech Scientific - Ruan Xingmei Resigns as Executive Director

THOMSON REUTERS
·
Nov 21, 2025

LifeTech Scientific - Wu Liping and Fang Yu Appointed as Executive Directors

THOMSON REUTERS
·
Nov 21, 2025

LifeTech Scientific - Feng Xiaoling Appointed as Executive Director

THOMSON REUTERS
·
Nov 21, 2025

LifeTech Scientific (SEHK:1302): Valuation Insights Following China Approval of G-BranchTM Stent Graft System

Simply Wall St.
·
Nov 14, 2025

LIFETECH SCI (01302): G-BranchTM Thoracoabdominal Aortic Stent Graft System Receives Official Registration Approval from NMPA

Stock News
·
Nov 06, 2025

LifeTech Scientific Wins China NMPA Approval for G-Branch Thoracoabdominal Artery Stent Graft System

Reuters
·
Nov 06, 2025

LifeTech Scientific - G-Branch Thoracoabdominal Artery Stent Graft System Approved by China Nmpa

THOMSON REUTERS
·
Nov 06, 2025

LifeTech Scientific (01302) Announces October 2025 Monthly Return

Bulletin Express
·
Nov 05, 2025

LIFETECH SCI (01302) Announces Two-Year Follow-Up Results of Phase II and Phase III Clinical Studies for IBS® Bioabsorbable Drug-Eluting Coronary Stent System

Stock News
·
Oct 29, 2025

LifeTech Scientific Corporation (1302) Releases Two-Year Follow-Up Clinical Results for IBS® Coronary Scaffold

Bulletin Express
·
Oct 29, 2025

LifeTech Scientific Reports Two-Year Clinical Results for IBS Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold

Reuters
·
Oct 29, 2025

Can Mixed Fundamentals Have A Negative Impact on LifeTech Scientific Corporation (HKG:1302) Current Share Price Momentum?

Simply Wall St.
·
Oct 19, 2025